The Insulin in Dosage Market Size Value Per Capita in South Africa demonstrated fluctuating trends between 2012 and 2022, starting at 3.73% in 2012 and ending at 3.08% in 2022. The market showed significant variability year-on-year, with notable declines in certain years. Over the last two years, there was a minor decline, with values decreasing from 3.25% in 2021 to 3.08% in 2022, showing a drop of approximately 5.2%. The CAGR over the last five years (2017-2022) was relatively stable with minor variations, indicating an average annual slight decrease of around 1.1%.
Future trends to watch for include potential advancements in insulin delivery technologies, emerging alternative therapies, and the impact of policy changes on diabetic care in South Africa. Additionally, monitoring population growth, changes in healthcare access, and economic factors will be critical in forecasting market evolution.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 19 | 19 Switzerland | 6.34 | 2023 | View data | ||
| 20 | 20 China | 3.49 | 2023 | View data | ||
| 21 | 21 South Africa | 3.11 | 2023 | |||
| 22 | 22 Morocco | 1.13 | 2023 | View data | ||
